OTE eNews Flyer

Article

OTE eNews Flyer

Recent Videos
Dr Rick Lewis discusses the FLigHT procedure and ViaLase laser at the 2024 European Society of Cataract and Refractive Surgeons (ESCRS) meeting
Christiana Dinah speaks about her ASRS presentation, Real-World Treatment Outcomes With Anti-VEGF Therapy in Patients With Retinal Vein Occlusion in the UK
Chase Ludwig, MD, shared an overview of his presentation, which covered real-impact of vitrectomy surgery on the progression of AMD at the annual ASRS meeting in Stockholm, Sweden
Thomas Aaberg, MD, gives an update on Neurotech Pharmaceuticals NT-501 device for the potential treatment of retinitis pigmentosa and age-related macular degeneration, including a projected PDUFA date from the FDA at the annual ASRS meeting in Stockholm, Sweden.
Sruthi Arepalli, MD, spoke with Modern Retina about her presentation, "Assessing retinal vascular changes in alzheimer disease with radiomics: A preliminary study of fundus photography" at the annual ASRS meeting in Stockholm, Sweden.
Nathan Steinle, MD, spoke with Modern Retina about the ongoing research on the durability of sozinibercept in combination therapy with anti-VEGF-A treatments at the annual ASRS meeting in Stockholm, Sweden.
Deepak Sambhara, MD, shared an overview of his paper-on-demand, which covered real-world safety and efficacy of aflibercept, 8 mg in the treatment of neovascular age-related macular degeneration at the annual ASRS meeting in Stockholm, Sweden.
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Related Content
Michael Goldstein, MD, speaks about his 2024 ESCRS presentation with Hattie Hayes of Ophthalmology Times Europe

ESCRS 2024: Approaching a paradigm shift in cell therapy for corneal oedema and endothelial dysfunction

Hattie Hayes
September 9th 2024
Article

Michael Goldstein, MD, discusses 12-month safety and efficacy trial data of human corneal endothelial cell therapy, presented at the 2024 ESCRS Congress

PHOTON Results and Their Relation to DME Patients in Your Practice

PHOTON Results and Their Relation to DME Patients in Your Practice

July 25th 2024
Podcast

John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.

A woman driving at night touches her eye. Image credit: ©Drazen – stock.adobe.com

ESCRS 2024: A new EDOF IOL brings functional outcomes into the spotlight

Hattie Hayes
September 7th 2024
Article

Professor Gerd Auffarth shares patients’ and colleagues’ responses to a new IOL with a monofocal-like dysphotopsia profile

PULSAR Results and Their Relation to nAMD Patients in Your Practice

PULSAR Results and Their Relation to nAMD Patients in Your Practice

July 24th 2024
Podcast

John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.

Miniature figures with backpacks stand on a map of Europe. Image credit: ©kirill_makarov – stock.adobe.com

Unite and conquer: Refractive surgery goes on a world tour

Hattie Hayes
September 4th 2024
Article

The ESCRS Moving Simulator initiative brings surgical training to nations in need

Barcelona at night, specifically the area around Fira de Barcelona convention center. Image credit: ©JackF – stock.adobe.com

Filomena Ribeiro, MD, PhD, FEBO, discusses escape rooms, inclusivity initiatives and everything else ESCRS

Hattie Hayes
September 4th 2024
Article

Dr Ribeiro, President of the European Society of Cataract and Refractive Surgeons, previewed the 2024 congress

© 2024 MJH Life Sciences

All rights reserved.